CME Group Inc. (NASDAQ:CME) to Post Q1 2024 Earnings of $2.28 Per Share, Zacks Research Forecasts

CME Group Inc. (NASDAQ:CMEFree Report) – Investment analysts at Zacks Research raised their Q1 2024 EPS estimates for CME Group in a report issued on Monday, February 5th. Zacks Research analyst T. De now forecasts that the financial services provider will post earnings per share of $2.28 for the quarter, up from their prior estimate of $2.27. The consensus estimate for CME Group’s current full-year earnings is $9.24 per share. Zacks Research also issued estimates for CME Group’s Q2 2024 earnings at $2.23 EPS, Q4 2024 earnings at $2.46 EPS, FY2024 earnings at $9.20 EPS, Q4 2025 earnings at $2.38 EPS and FY2025 earnings at $9.36 EPS.

Other equities analysts have also issued reports about the stock. The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective on the stock. in a report on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a report on Wednesday, October 11th. Rosenblatt Securities reissued a “sell” rating and set a $180.00 price objective on shares of CME Group in a report on Thursday, January 4th. Morgan Stanley lifted their price target on shares of CME Group from $215.00 to $220.00 and gave the stock an “equal weight” rating in a report on Thursday, October 26th. Finally, Barclays lowered shares of CME Group from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $244.00 to $222.00 in a report on Monday, January 8th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $213.89.

View Our Latest Analysis on CME

CME Group Stock Performance

Shares of CME stock opened at $205.46 on Tuesday. The firm has a market cap of $73.96 billion, a price-to-earnings ratio of 24.52, a PEG ratio of 2.36 and a beta of 0.48. The company’s 50 day moving average is $207.58 and its 200 day moving average is $207.66. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group has a 52-week low of $174.01 and a 52-week high of $223.80.

CME Group Increases Dividend

The business also recently disclosed a None dividend, which was paid on Thursday, January 18th. Stockholders of record on Thursday, December 28th were issued a dividend of $5.25 per share. The ex-dividend date was Wednesday, December 27th. This is a positive change from CME Group’s previous None dividend of $4.50. CME Group’s payout ratio is 52.51%.

Insider Activity

In related news, insider Derek Sammann sold 1,862 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.07, for a total transaction of $413,494.34. Following the completion of the transaction, the insider now directly owns 9,694 shares in the company, valued at $2,152,746.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider Derek Sammann sold 1,862 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.07, for a total transaction of $413,494.34. Following the completion of the transaction, the insider now directly owns 9,694 shares in the company, valued at $2,152,746.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bryan T. Durkin sold 5,560 shares of the business’s stock in a transaction on Monday, December 11th. The shares were sold at an average price of $216.37, for a total transaction of $1,203,017.20. Following the transaction, the director now owns 62,452 shares of the company’s stock, valued at $13,512,739.24. The disclosure for this sale can be found here. Insiders have sold 18,103 shares of company stock valued at $3,971,672 over the last ninety days. 0.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of CME. Bank of Hawaii increased its stake in shares of CME Group by 2.0% during the second quarter. Bank of Hawaii now owns 5,480 shares of the financial services provider’s stock worth $1,015,000 after purchasing an additional 109 shares in the last quarter. Artisan Partners Limited Partnership grew its stake in shares of CME Group by 16.2% in the 2nd quarter. Artisan Partners Limited Partnership now owns 479,481 shares of the financial services provider’s stock valued at $88,843,000 after buying an additional 66,703 shares during the period. Yousif Capital Management LLC grew its stake in shares of CME Group by 3.0% in the 2nd quarter. Yousif Capital Management LLC now owns 59,146 shares of the financial services provider’s stock valued at $10,959,000 after buying an additional 1,717 shares during the period. Impax Asset Management Group plc lifted its holdings in shares of CME Group by 104.7% in the 2nd quarter. Impax Asset Management Group plc now owns 286,050 shares of the financial services provider’s stock worth $53,002,000 after acquiring an additional 146,338 shares during the last quarter. Finally, Van Hulzen Asset Management LLC lifted its holdings in shares of CME Group by 544.7% in the 3rd quarter. Van Hulzen Asset Management LLC now owns 9,670 shares of the financial services provider’s stock worth $1,936,000 after acquiring an additional 8,170 shares during the last quarter. Institutional investors and hedge funds own 85.69% of the company’s stock.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.